Company logo

FMS - Fresenius Medical Care AG & Co. KGaA

NYSE -> Healthcare -> Medical Care Facilities
Bad Homburg, Germany
Type: Equity

FMS price evolution
FMS
(in millions $) 30 Jul 2024 1 May 2024 31 Jan 2024 30 Oct 2023
Current assets
Cash
Short term investments
Net receivables $4062.26 $4050.04 $3636.51 $3714.23
Inventory $2227.45 $2216.4 $2179.18 $2303.9
Total current assets $8689.93 $9282.68 $8701.41 $9054.21
Long term investments
Property, plant & equipment $7261.84 $7306.43 $7454.02 $7885.47
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $33896.2 $34336.1 $33929.81 $35634.7
Current liabilities
Accounts payable $783.68 $725.18 $762.07 $753.12
Deferred revenue
Short long term debt
Total current liabilities $5935.92 $6203.6 $6111.59 $6619.33
Long term debt $10332.41 $10509.37 $10488.85 $11067.1
Total noncurrent liabilities
Total debt
Total liabilities $19964.6 $20428.74 $20309.55 $21628.14
Shareholders' equity
Retained earnings $10871.95 $11027.13 $10921.69 $10759.2
Other shareholder equity -$620.46 -$798.77 -$975.17 -$424.13
Total shareholder equity
(in millions $) 31 Jan 2024 31 Jan 2023 30 Dec 2021 30 Dec 2020
Current assets
Cash $1079.06 $911.01 $1481.65 $1081.54
Short term investments $159.18 $179.26
Net receivables $3857.16 $3882.04 $3906.68 $3619.04
Inventory $2179.18 $2296.21 $2038.01 $1895.31
Total current assets $8701.41 $8203.45 $7967.24 $7275.31
Long term investments $786.9 $761.11
Property, plant & equipment $7454.02 $8339.81 $8551.47 $8186.75
Goodwill & intangible assets
Total noncurrent assets $27887.8
Total investments
Total assets $33929.81 $35754.11 $34366.56 $31689.04
Current liabilities
Accounts payable $762.07 $813.25 $818.51 $794.93
Deferred revenue
Short long term debt $667.97 $1008.36
Total current liabilities $6111.59 $6467.31 $7257.63 $6159.64
Long term debt $10488.85 $11175.67 $6646.95 $6800.1
Total noncurrent liabilities $15076.17
Total debt
Total liabilities $20309.55 $21764.66 $20387.52 $19357.73
Shareholders' equity
Retained earnings $10921.69 $10711.71 $10826.14 $10254.91
Other shareholder equity -$975.17 -$388.47 -$1311.64 -$2205.34
Total shareholder equity $12698.78 $11215.08
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Jan 2024
Revenue
Total revenue $4724.52
Cost of revenue
Gross Profit $1173.65
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $884
Operating income
Income from continuing operations
EBIT
Income tax expense $39.51
Interest expense -$129.76
Net income
Net income $70.96
Income (for common shares)
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 30 Dec 2020
Revenue
Total revenue $19454 $19398.02 $17859.06
Cost of revenue $12321.62
Gross Profit $4925 $5310.25 $5537.44
Operating activities
Research & development $193.77
Selling, general & administrative $2996.44
Total operating expenses $3678 $3757.49 $15511.83
Operating income $2347.23
Income from continuing operations
EBIT $2347.23
Income tax expense $301 $324.95 $500.56
Interest expense -$214 -$322.34 -$409.98
Net income
Net income $499 $673.4 $1164.38
Income (for common shares) $1164.38
(in millions $) 30 Jul 2024 1 May 2024 31 Jan 2024 30 Oct 2023
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing $254.19 -$68.37 -$544.23 -$447.73
Financing activities
Dividends paid -$349.16 -$328.62 -$328.62
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$1127.03 -$289.66 -$1858.53 -$1112.88
Effect of exchange rate -$12.23 -$4.51 -$72.61 -$48.56
Change in cash and equivalents -$315.35 -$235.23 $153.44 $300.57
(in millions $) 31 Jan 2024 31 Jan 2023 30 Dec 2021 30 Dec 2020
Net income $969.31 $1164.38
Operating activities
Depreciation $1535.58 $1543.55
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $2489.5 $4233.16
Investing activities
Capital expenditures -$854.36 -$1051.98
Investments -$61.58 -$65.06
Total cash flows from investing -$544.23 -$734.73 -$1196.23 -$1334.94
Financing activities
Dividends paid -$328.62 -$395.56 -$392.45 -$351.17
Sale and purchase of stock
Net borrowings -$358.9 -$1639.83
Total cash flows from financing -$1858.53 -$1617.36 -$1024.38 -$2664.03
Effect of exchange rate -$72.61 -$23.16 $131.23 -$160.37
Change in cash and equivalents $153.44 -$207.87 $400.12 $73.82
Fundamentals
Market cap $13.39B
Enterprise value N/A
Shares outstanding 586.83M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 1.46
Quick ratio 1.09